Vimarsana
Biggest News Aggregation in the World

Page 41 - Devika Syamnath News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Devika Syamnath. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Devika Syamnath Today - Breaking & Trending Today

US smartphone sales slump in January on fewer device upgrades, Counterpoint finds - Vimarsana News

US smartphone sales slump in January on fewer device upgrades, Counterpoint finds

(Reuters) - U.S. smartphone sales plunged 10% in January on weak demand for cheaper Android devices and as customers delayed upgrades ahead of the launch of Samsung Electronics' Galaxy S24 series, according to data from Counterpoint Research. The r...

Source: whbl.com
US smartphone sales slump in January on fewer device upgrades, Counterpoint finds - Vimarsana News

US smartphone sales slump in January on fewer device upgrades, Counterpoint finds

(Reuters) - U.S. smartphone sales plunged 10% in January on weak demand for cheaper Android devices and as customers delayed upgrades ahead of the launch of Samsung Electronics' Galaxy S24 series, according to data from Counterpoint Research. The r...

Source: wsau.com
US smartphone sales slump in January on fewer device upgrades, Counterpoint finds - Vimarsana News

US smartphone sales slump in January on fewer device upgrades, Counterpoint finds

(Reuters) - U.S. smartphone sales plunged 10% in January on weak demand for cheaper Android devices and as customers delayed upgrades ahead of the launch of Samsung Electronics' Galaxy S24 series, according to data from Counterpoint Research.

S&P Global to buy Visible Alpha for undisclosed sum - Vimarsana News

S&P Global to buy Visible Alpha for undisclosed sum

-Data provider S&P Global said on Tuesday it plans to buy financial technology provider Visible Alpha for an undisclosed sum. ... -February 20, 2024 at 07:16 am EST - MarketScreener

FDA puts on hold two Rapt Therapeutics mid-stage drug trials - Vimarsana News

FDA puts on hold two Rapt Therapeutics mid-stage drug trials

Rapt Therapeutics said on Tuesday the U.S. FDA had placed on hold two mid-stage trials of the company's drug to treat eczema and asthma, after liver failure was observed in one of the patients. ...